Logo

Helicos

China's GeneMind Biosciences Launches GenoCare 1600 Single-Molecule Sequencer
Premium

The sequencing-by-synthesis platform, using technology originally developed by Helicos, was approved by China's NMPA for noninvasive prenatal testing earlier this year.

China NMPA Approves GeneMind GenoCare 1600 Sequencer for Noninvasive Prenatal Testing

The sequencer, produced by Chinese sequencing tech company GeneMind Biosciences, is approved for noninvasive prenatal testing to detect common trisomies.

SeqLL Withdraws Plans for $8M IPO

The Massachusetts sequencing firm has been selling technology originally developed by Helicos BioSciences and planned to increase marketing with the IPO proceeds.

True Bearing Readies RNA-Based Coronary Artery Disease Diagnostic for FDA Review, Launch
Premium

The company is collecting validation evidence it intends to submit to the FDA next year, which will also support launch of  the test as an LDT.

SeqLL Launches Early Access for Revamped Helicos Platform, Expands Service Business
Premium

The company plans to raise $25 million in a Series B financing round. It is also working on a two-color chemistry and aims to develop an instrument for clinical applications.

Oct 27, 2015

China's Direct Genomics Unveils New Targeted NGS System Based on Helicos Tech for Clinical Use
Premium

Sep 30, 2014

SeqLL Plans to Revamp Helicos Technology
Premium

Sep 18, 2014

SeqLL Raises $1M to Enhance Service Offerings on Helicos Single-Molecule Platform

Mar 11, 2014

Pathogen Search Underscores Need for Validation Steps When Sequencing Ancient Metagenomes
Premium

Nov 8, 2013

Fruit Fly Study Hints at RNA Editing Effect on Transposon-related Gene Silencing

Jun 17, 2013

Bankruptcy Court OKs Helicos' IP License Deals with Illumina, Life Tech, Fluidigm, Complete Genomics; Negotiations Ongoing with Roche

May 17, 2013

Helicos Seeks Bankruptcy Court Approval of Licensing Deals with Illumina, Life Tech, and Fluidigm

Mar 11, 2013

Helicos Seeks Approval to Sell Assets, IP to Employee to Form New Company

Dec 18, 2012

As Helicos Navigates Bankruptcy Process, Details Emerge on Disputes with Creditors and Customers
Premium

Nov 16, 2012

Helicos BioSciences Files for Chapter 11 Bankruptcy Protection

Oct 2, 2012

Paired Ends: Carol Cox, Louise Mawhinney
Premium

Sep 11, 2012

Paired Ends: Ivan Trifunovich, Andrew Senyei, Paul Bianchi, and More
Premium

Sep 7, 2012

Helicos CEO Resigns

Sep 4, 2012

Helicos Considers Next Moves as Remaining Patent in Illumina Suit Is Deemed Invalid
Premium

Sep 4, 2012

Paired Ends: Noubar Afeyan, Peter Barrett, Daniel O'Day, Pascal Soriot, Roland Diggelman
Premium

Aug 30, 2012

Federal Court Rules Helicos Patent Invalid; Company Reaches Payment Agreement with Lenders

Aug 14, 2012

Helicos Q2 Sales Fall on Lower Grant, Service Revenues

Aug 7, 2012

Helicos Licenses Patents to Intelligent Bio-Systems for $1.6M

Jul 10, 2012

Helicos Drops Suit Against Life Tech, Leaving Illumina as Sole Defendant
Premium

May 14, 2012

Helicos Posts Sharp Drop in Q1 Revenues

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.